Orleans Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.41M | Hold |
15,683
| – | – | 2.31% | 11 |
|
|
2025
Q4 | $3.58M | Sell |
15,683
-132
| -0.8% | -$30.1K | 2.23% | 11 |
|
|
2025
Q3 | $3.66M | Sell |
15,815
-5,110
| -24% | -$1.04M | 2.37% | 11 |
|
|
2025
Q2 | $3.88M | Buy |
20,925
+85
| +0.4% | +$15.8K | 2.06% | 13 |
|
|
2025
Q1 | $4.37M | Sell |
20,840
-40
| -0.2% | -$7.78K | 2.57% | 7 |
|
|
2024
Q4 | $4.01M | Buy |
20,880
+270
| +1% | +$49.6K | 2.24% | 10 |
|
|
2024
Q3 | $4.07M | Sell |
20,610
-90
| -0.4% | -$16.8K | 2.31% | 10 |
|
|
2024
Q2 | $3.55M | Buy |
20,700
+10
| +0% | +$1.66K | 2.26% | 10 |
|
|
2024
Q1 | $3.77M | Sell |
20,690
-1,313
| -6% | -$226K | 2.47% | 9 |
|
|
2023
Q4 | $3.41M | Buy |
22,003
+520
| +2% | +$75.8K | 2.29% | 14 |
|
|
2023
Q3 | $3.2M | Sell |
21,483
-955
| -4% | -$140K | 2.38% | 11 |
|
|
2023
Q2 | $3.02M | Sell |
22,438
-10,223
| -31% | -$1.5M | 2.15% | 15 |
|
|
2023
Q1 | $5.21M | Sell |
32,661
-500
| -2% | -$76.4K | 3.84% | 4 |
|
|
2022
Q4 | $5.36M | Sell |
33,161
-246
| -0.7% | -$37.7K | 4.1% | 4 |
|
|
2022
Q3 | $4.48M | Sell |
33,407
-2,000
| -6% | -$287K | 3.75% | 6 |
|
|
2022
Q2 | $5.42M | Sell |
35,407
-74
| -0.2% | -$11.3K | 4.05% | 4 |
|
|
2022
Q1 | $5.75M | Buy |
35,481
+895
| +3% | +$130K | 3.57% | 4 |
|
|
2021
Q4 | $4.68M | Buy |
34,586
+1,112
| +3% | +$131K | 2.66% | 11 |
|
|
2021
Q3 | $3.61M | Buy |
33,474
+6,900
| +26% | +$788K | 2.3% | 13 |
|
|
2021
Q2 | $2.99M | Sell |
26,574
-250
| -0.9% | -$28.2K | 1.92% | 21 |
|
|
2021
Q1 | $2.9M | Sell |
26,824
-240
| -0.9% | -$25.7K | 1.97% | 22 |
|
|
2020
Q4 | $2.9M | Buy |
27,064
+445
| +2% | +$42.8K | 2.09% | 20 |
|
|
2020
Q3 | $2.33M | Buy |
26,619
+4,450
| +20% | +$419K | 1.78% | 23 |
|
|
2020
Q2 | $2.18M | Buy |
+22,169
| New | +$1.95M | 1.78% | 20 |
|
|
2020
Q1 | – | Sell |
-24,404
| Closed | -$2.16M | – | 30 |
|
|
2019
Q4 | $2.16M | Buy |
24,404
+30
| +0.1% | +$2.49K | 1.52% | 29 |
|
|
2019
Q3 | $1.85M | Sell |
24,374
-2,968
| -11% | -$203K | 1.37% | 32 |
|
|
2019
Q2 | $1.99M | Sell |
27,342
-7,400
| -21% | -$582K | 1.5% | 32 |
|
|
2019
Q1 | $2.8M | Sell |
34,742
-640
| -2% | -$52.4K | 2.15% | 14 |
|
|
2018
Q4 | $3.26M | Sell |
35,382
-700
| -2% | -$61.6K | 3.04% | 5 |
|
|
2018
Q3 | $3.41M | Sell |
36,082
-900
| -2% | -$85.3K | 2.34% | 8 |
|
|
2018
Q2 | $3.43M | Sell |
36,982
-50
| -0.1% | -$4.88K | 2.47% | 8 |
|
|
2018
Q1 | $3.5M | Sell |
37,032
-1,420
| -4% | -$156K | 2.57% | 8 |
|
|
2017
Q4 | $3.72M | Sell |
38,452
-87
| -0.2% | -$8.2K | 2.65% | 9 |
|
|
2017
Q3 | $3.42M | Sell |
38,539
-1,821
| -5% | -$139K | 2.56% | 10 |
|
|
2017
Q2 | $2.93M | Sell |
40,360
-190
| -0.5% | -$12.8K | 2.07% | 22 |
|
|
2017
Q1 | $2.64M | Buy |
40,550
+85
| +0.2% | +$5.34K | 1.84% | 22 |
|
|
2016
Q4 | $2.53M | Buy |
40,465
+980
| +2% | +$59.8K | 1.81% | 22 |
|
|
2016
Q3 | $2.49M | Buy |
39,485
+2,200
| +6% | +$142K | 1.73% | 26 |
|
|
2016
Q2 | $2.31M | Buy |
37,285
+3,874
| +12% | +$236K | 1.61% | 27 |
|
|
2016
Q1 | $1.91M | Sell |
33,411
-143
| -0.4% | -$7.97K | 1.44% | 27 |
|
|
2015
Q4 | $1.99M | Sell |
33,554
-96
| -0.3% | -$5.53K | 1.53% | 26 |
|
|
2015
Q3 | $1.83M | Sell |
33,650
-763
| -2% | -$49.7K | 1.45% | 30 |
|
|
2015
Q2 | $2.31M | Sell |
34,413
-1,711
| -5% | -$112K | 1.63% | 23 |
|
|
2015
Q1 | $2.12M | Sell |
36,124
-3,042
| -8% | -$184K | 1.37% | 33 |
|
|
2014
Q4 | $2.56M | Sell |
39,166
-8,511
| -18% | -$537K | 1.56% | 29 |
|
|
2014
Q3 | $2.75M | Sell |
47,677
-133
| -0.3% | -$7.38K | 1.35% | 32 |
|
|
2014
Q2 | $2.7M | Buy |
47,810
+325
| +0.7% | +$17.1K | 1.26% | 33 |
|
|
2014
Q1 | $2.44M | Buy |
47,485
+1
| +0% | +$51 | 1.24% | 36 |
|
|
2013
Q4 | $2.51M | Sell |
47,484
-734
| -2% | -$36.1K | 1.3% | 35 |
|
|
2013
Q3 | $2.16M | Sell |
48,218
-7,289
| -13% | -$323K | 1.17% | 38 |
|
|
2013
Q2 | $2.29M | Buy |
+55,507
| New | +$2.43M | 1.29% | 33 |
|
Other funds holding ABBV
VCM
VPM
Orleans Capital Management's ABBV Position: Q1 2026 in Review
Orleans Capital Management held its AbbVie (ABBV) position steady in Q1 2026 at 15,683 shares worth $3.41M. The position accounts for 2.31% of the portfolio, ranked #11.
Orleans Capital Management first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.75M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Orleans Capital Management held 15,683 shares of AbbVie worth $3.41M as of Q1 2026.
- Orleans Capital Management left its AbbVie share count unchanged in Q1 2026.
- AbbVie made up 2.31% of Orleans Capital Management's portfolio in Q1 2026, its #11 holding.
- Orleans Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Orleans Capital Management's AbbVie position peaked at $5.75M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Orleans Capital Management's 13F filing for Q1 2026, filed 14 May 2026.